miRNA-378 reverses chemoresistance to cisplatin in lung adenocarcinoma cells by targeting secreted clusterin

Cisplatin resistance is a major obstacle in the treatment of NSCLC, and its mechanism has not been fully elucidated. The objectives of the study were to determine the role of miR-378 in the sensitivity of lung adenocarcinoma cells to cisplatin (cDDP) and its working mechanism. With TargetScan and lu...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xuesong, Jiang, Ying, Huang, Zheping, Li, Dandan, Chen, Xiaodi, Cao, Mengru, Meng, Qingwei, Pang, Hui, Sun, Lichun, Zhao, Yanbin, Cai, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4725983/
https://www.ncbi.nlm.nih.gov/pubmed/26781643
http://dx.doi.org/10.1038/srep19455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4725983/
https://www.ncbi.nlm.nih.gov/pubmed/26781643
http://dx.doi.org/10.1038/srep19455

Ejemplares similares